Clinical Trials Browser

Recruiting × Neoplasms × Ramucirumab × Clear all

NCT05999994 2026-03-27

CAMPFIRE

Phase 2 Recruiting

Neoplasms

NCT05894824 2025-07-11

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 1/2 Recruiting

Gastrointestinal

Neoplasms, Stomach Neoplasms